POCINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30

PRECISION OPTICS CORPORATION, INC.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026

$4.27−0.05 (-1.16%)

Close on Oct 19, 2026

Market cap: $46.54M
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt

$1.29M

$577.90K due within a year

Net debt

-$8.55M

After $9.84M of cash

Implied interest rate

9.39%

FY2026 interest ÷ average debt

Interest coverage

-23.7×

FY2026 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Precision Optics's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Precision Optics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-3 reverse split on Feb 14, 2023
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is POCI.

Revenue growth65.2% · median 3.7%

Gross margin17.2% · median 35.9%

Operating margin-11.1% · median -4.6%

Net margin-11.5% · median -6.9%

Company	Revenue	Growth
PDEX	$77.55M	+16.5%
IRIX	$51.57M	+3.7%
POCI	$31.53M	+65.2%
STXS	$30.07M	-5.5%
OPTX	$29.24M	+1.5%
ESMC	$12.74M	+5.7%

Company

Exchange: Nasdaq
Industry: Electromedical & Electrotherapeutic Apparatus
Fiscal year ends: June 30
Employees: 108
Held by institutions: 35.9%
Auditor: Stowe & Degon LLC
SEC CIK: 867840

Advertisement
300 × 250